Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.3462
+0.0359 (11.57%)
At close: Nov 13, 2025, 4:00 PM EST
0.3000
-0.0462 (-13.34%)
After-hours: Nov 13, 2025, 4:53 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $1.95 million as of November 13, 2025. Its market cap has decreased by -66.13% in one year.
Market Cap
1.95M
Enterprise Value
-1.77M
1-Year Change
-66.13%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $1.95M, a decrease of -92.55%. That is a compound annual growth rate of -45.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 1.70M | -71.96% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
| Aug 16, 2021 | 26.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |